![Carl Weissman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carl Weissman
Directeur Général chez
ISB Accelerator Corp.
Profil
Carl Weissman was the founder of Accelerator Services Corp, founded in 2003, serving as Chairman & CEO from 2003 to 2014.
Mr. Weissman is currently Chief Executive Officer at ISB Accelerator Corp., a position held since 2003.
Former jobs include President & Chief Executive Officer at Homestead Clinical Corp., Director at Allozyne, Inc., Groove Biopharma Corp., Oncofactor Corp., Viral Logic Systems Technology Corp., Novomer, Inc., and Fate Therapeutics, Inc., President & Director at Acylin Therapeutics, Inc., President at XORI Corp., President at Nevis Brands, Inc. in 2019, and Venture Partner at MPM BioImpact LLC from 2001 to 2008.
Postes actifs de Carl Weissman
| Sociétés | Poste | Début |
|---|---|---|
ISB Accelerator Corp.
 ISB Accelerator Corp. Miscellaneous Commercial ServicesCommercial Services Involved in the study of biological systems | Directeur Général | 01/01/2003 |
Anciens postes connus de Carl Weissman
| Sociétés | Poste | Fin |
|---|---|---|
| NEVIS BRANDS INC. | President | 04/07/2019 |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services invests in companies located in the United States. The firm focuses on the healthcare sector. It provides financing for early stage capital requirements. | Directeur Général | 30/06/2014 |
Homestead Clinical Corp.
 Homestead Clinical Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | President | 27/11/2009 |
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Private Equity Investor | 30/06/2008 |
Novomer, Inc.
 Novomer, Inc. Industrial SpecialtiesProcess Industries Manufactures biodegradable plastics, polymers and other chemicals from renewable substances | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
52
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
ISB Accelerator Corp.
ISB Accelerator Corp. Miscellaneous Commercial ServicesCommercial Services Involved in the study of biological systems | Commercial Services |
Homestead Clinical Corp.
Homestead Clinical Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Allozyne, Inc.
 Allozyne, Inc. Medical SpecialtiesHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Groove Biopharma Corp.
 Groove Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Focuses on the generation of novel microRNA therapeutics | Commercial Services |
XORI Corp.
 XORI Corp. BiotechnologyHealth Technology Provides health technology services | Health Technology |
Oncofactor Corp.
 Oncofactor Corp. Pharmaceuticals: MajorHealth Technology Develops antibody drugs against new biologic targets in cancer | Health Technology |
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
Viral Logic Systems Technology Corp.
 Viral Logic Systems Technology Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutics for autoimmune and inflammatory disorders | Health Technology |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services invests in companies located in the United States. The firm focuses on the healthcare sector. It provides financing for early stage capital requirements. | Finance |
Novomer, Inc.
Novomer, Inc. Industrial SpecialtiesProcess Industries Manufactures biodegradable plastics, polymers and other chemicals from renewable substances | Process Industries |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Acylin Therapeutics, Inc.
 Acylin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhibitors of cellular acylation | Health Technology |
Nevis Brands, Inc.
 Nevis Brands, Inc. BiotechnologyHealth Technology Engages in the research on the field of immunotherapy | Health Technology |
